Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants.
about
Gut microbiota role in irritable bowel syndrome: New therapeutic strategiesBifidobacterium longum subspecies infantis: champion colonizer of the infant gutRisk and safety of probioticsFecal calprotectin excretion in preterm infants during the neonatal periodCan probiotics modulate human disease by impacting intestinal barrier function?Effect of Bifidobacterium animalis subsp lactis supplementation in preterm infants: a systematic review of randomized controlled trials.A fermented formula in pre-term infants: clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA.Lactobacillus acidophilus/Bifidobacterium infantis probiotics are associated with increased growth of VLBWI among those exposed to antibiotics.Is early nutrition related to short-term health and long-term outcome?The ProPrems trial: investigating the effects of probiotics on late onset sepsis in very preterm infants.Facultative to strict anaerobes ratio in the preterm infant microbiota: a target for intervention?Role of secretory IgA in the mucosal sensing of commensal bacteria.How can probiotics and prebiotics impact mucosal immunity?The multifaceted role of commensal microbiota in homeostasis and gastrointestinal diseases.Novel probiotic Bifidobacterium longum subsp. infantis CECT 7210 strain active against rotavirus infections.Gut microbiota and inflammation.Effect of yoghurt containing Bifidobacterium lactis Bb12® on faecal excretion of secretory immunoglobulin A and human beta-defensin 2 in healthy adult volunteers.Combinational effects of prebiotic oligosaccharides on bifidobacterial growth and host gene expression in a simplified mixed culture model and neonatal mice.Study of the Ability of Bifidobacteria of Human Origin to Prevent and Treat Rotavirus Infection Using Colonic Cell and Mouse Models.Prognostic impact of fecal pH in critically ill patients.Effect of long-term antibiotic use on weight in adolescents with acne.Effect of Infant Formula Containing a Low Dose of the Probiotic Bifidobacterium lactis CNCM I-3446 on Immune and Gut Functions in C-Section Delivered Babies: A Pilot StudyImpact of Dietary Lipids on Colonic Function and Microbiota: An Experimental Approach Involving Orlistat-Induced Fat Malabsorption in Human Volunteers.Importance of gut microbiota in health and diseases of new born infants.The use of probiotic strains in caries prevention: a systematic review.Recent developments in necrotizing enterocolitis.Probiotics in neonatology.Probiotics, prebiotics infant formula use in preterm or low birth weight infants: a systematic review.The role of probiotics and prebiotics in inducing gut immunity.Lactobacillus-produced exopolysaccharides and their potential health benefits: a review.Multiple strains probiotics appear to be the most effective probiotics in the prevention of necrotizing enterocolitis and mortality: An updated meta-analysis.Probiotic and synbiotic safety in infants under two years of age.Early intervention with Bifidobacterium lactis NCC2818 modulates the host-microbe interface independent of the sustained changes induced by the neonatal environment.Bifidobacterium bifidum OLB6378 Simultaneously Enhances Systemic and Mucosal Humoral Immunity in Low Birth Weight Infants: A Non-Randomized Study.Influence of a combination of probiotics on bacterial infections in very low birthweight newborns.Short-term, daily intake of yogurt containing Bifidobacterium animalis ssp. lactis Bf-6 (LMG 24384) does not affect colonic transit time in women.Dietary supplementation with Bifidobacterium lactis NCC2818 from weaning reduces local immunoglobulin production in lymphoid-associated tissues but increases systemic antibodies in healthy neonates.Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.EFFECTS OF PROBIOTIC INTAKE ON INTESTINAL BIFIDOBACTERIA OF CELIAC PATIENTS.Lower bifidobacteria counts in adult patients with celiac disease on a gluten-free diet.
P2860
Q26768550-FFBFD557-DC45-48E2-8D8E-1104D41B0649Q26823017-16E88408-63D4-4EE8-A928-FF1B9096B12CQ28087466-5A5863E5-7D96-4EB1-B51E-ACF1EF49F7A4Q28751670-A7FBE6D2-B4EB-4EF8-BC18-67214E7B2029Q28817192-AC3997C4-1D6C-4A39-B44E-9621C003AD36Q33602922-E4E6FA03-97F8-49F6-869E-F2A29F935414Q33852692-6867BB44-632B-4E4F-B70A-4951E6800138Q33912012-FC38E9DE-BA8E-4211-BCBC-D88E45C34FD6Q33941931-AC5C9CCC-6F54-402A-BB98-C48CF57590CCQ33982024-7A724912-F35F-4CC2-8B8B-30E2EC7269D0Q34393663-9988C782-B7ED-4C8A-92EB-224593B87F90Q34455427-A7FE596E-8C8C-4720-B8E6-B85EE05645FFQ34503641-DD6FB296-9634-4C75-B1E7-42452F1BA7AFQ35156014-BB33778E-8104-402B-8BE9-901BCCB2E197Q35599181-05217579-E18B-489E-92C1-B9A1E4F94F7BQ35670894-89532A54-9D66-4D66-8CB1-CE3422D3EA62Q35692759-7B0DB3CC-E206-431C-8B75-557B721D9CBAQ36023124-5C7D7FF6-49F9-4A74-A1A9-97FFB137BB74Q36160564-A72284B7-C6E7-42C3-BDAA-AFC9DE7CB9EBQ36633838-4B80A28B-805C-41F5-955B-93F2AE0D976EQ36684193-12FD0A07-64E4-4514-A506-40C5B8E3CECFQ36688031-869DE2BB-BACF-483E-B064-0108384977E7Q36864727-91D060BC-7E68-4F4D-A25F-230BB8441D6DQ37001049-D6CF0EFD-029A-4632-8C5F-0B3EFC941EE2Q37083793-553AD3C5-ADD3-44DE-9438-DD0C484AB5A0Q37975157-10F83DD9-25E3-4D33-8693-EB480D27E779Q38031980-ACA679E4-0412-4366-918B-4225D53229C4Q38038697-59A30139-A9CD-4807-8337-E12AD60CCA40Q38174603-99F3AD55-C9C2-4D91-BC09-66D28B57DD3FQ38310740-8C2B333B-3E6A-47B5-8B5F-817B503859B8Q38969590-14571818-6735-4899-9DE8-84AD69BDFC2EQ39264265-B9EBFEA9-1E72-4DDE-BF17-FCA719D5BA24Q40135366-7C5EA5FE-8413-4205-ACE8-58BA91996CADQ40314175-800AB165-A080-460B-8E02-231E66BEA2A9Q40997854-2FD26038-B4D4-44DC-8CCD-B3A693A3743AQ43801369-971F20A7-8C08-4C8D-86E0-DAD40E7AA435Q44072920-2619E585-621F-408F-AC59-F7B8628D0F2DQ46236620-46B0F795-E166-4C35-B4A7-5502962CB5B6Q46407305-9E9803C8-719A-47AC-92AA-4669C69ECB62Q46869172-65234E12-BC88-4002-B57F-93B23A6BA047
P2860
Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Effects of Bifidobacterium lac ...... n, and IgA in preterm infants.
@en
Effects of Bifidobacterium lac ...... n, and IgA in preterm infants.
@nl
type
label
Effects of Bifidobacterium lac ...... n, and IgA in preterm infants.
@en
Effects of Bifidobacterium lac ...... n, and IgA in preterm infants.
@nl
prefLabel
Effects of Bifidobacterium lac ...... n, and IgA in preterm infants.
@en
Effects of Bifidobacterium lac ...... n, and IgA in preterm infants.
@nl
P2093
P2860
P1433
P1476
Effects of Bifidobacterium lac ...... in, and IgA in preterm infants
@en
P2093
Janko Schildt
Manfred Mueller
Michael Radke
Ruchika Mohan
P2860
P2888
P304
P356
10.1203/PDR.0B013E318181B7FA
P407
P577
2008-10-01T00:00:00Z
P6179
1032351473